The large, asymptomatic screening cohort analyzed constitutes another strength of our study, allowing the estimation of the diagnostic capability of methylated NEUROG1 in a real-life screening scenario that included a variety of colorectal pathologies. Here, NEUROG1 is linked to medical procedure.